January 2022

Integrative mechanisms underlying the evolution of drug resistance in oncogene-driven lung cancer: a QBI Online Seminar with Trever Bivona

Wednesday, March 2, 2022 - 9:00 am to 10:00 am

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the U.S. and Ireland. QBI and UCD recently signed a five-year memorandum of understanding (MOU) to reinforce the links between scientists in San Francisco and Dublin and enhance their collaborative ability to strengthen scientific research and innovation.

Kearney named interim dean of UCSF School of Pharmacy

The search for the School’s next dean is ongoing.

Chemistry-based strategies for investigating protein ADP-ribosylation: a QBI Online Seminar with Michael Cohen

Wednesday, February 9, 2022 - 11:00 am to 12:00 pm

The QBI Online Seminar Series presents Michael Cohen, an associate professor in the Department of Chemical Physiology and Biochemistry at Oregon Health and Science University (OHSU). Dr. Cohen received his BS in chemistry (cum laude) from UC Irvine and a PhD in chemical biology from UC San Francisco. During his graduate studies under the guidance of Dr.

Faculty members inducted into the Chan Zuckerberg Biohub Investigator Program

Gartner, Huang, Manglik, Kortemme, Savic, and Shipman honored for visionary research endeavors

Shipman lab pioneers more efficient genome editing

Recent findings from the laboratory of Seth Shipman, PhD, show that a type of bacterial DNA known as a retron can be harnessed to dramatically improve genome editing.